Literature DB >> 2738163

Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

J M Bennett1, D Catovsky, M T Daniel, G Flandrin, D A Galton, H R Gralnick, C Sultan.   

Abstract

Peripheral blood, bone marrow films, and bone marrow biopsy specimens from 110 patients, well characterised by clinical and laboratory studies, including electron microscopy, were reviewed, to determine proposals for the classification of chronic (mature) B and T cell leukaemias. On the basis of cytology and membrane phenotype the following disorders were defined: (i) B cell type: chronic lymphocytic leukaemia (CLL); CLL of mixed cell type, which includes cases with more than 10% and less than 55% prolymphocytes (CLL/PL), and a less well defined form with pleomorphic lymphocytes but less than 10% prolymphocytes; prolymphocytic leukaemia (PLL); hairy cell leukaemia (HCL); HCL variant; splenic lymphoma with circulating villous lymphocytes; leukaemic phase of non-Hodgkin's lymphoma (follicular lymphoma, intermediate, or mantle zone lymphoma and others); lymphoplasmacytic lymphoma with peripheral blood disease (mostly Waldenström's macroglobulinaemia); and plasma cell leukaemia. (ii) T cell type: T/CLL, which was differentiated from reactive T/lymphocytosis; T/PLL; adult T cell leukaemia/lymphoma; and Sézary's syndrome. The recognition of distinct entities within the B and T cell leukaemias seems to have clinical and epidemiological connotations. It is hoped that these proposals may serve as the basis for further work, discussion, and improved management of patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2738163      PMCID: PMC1141984          DOI: 10.1136/jcp.42.6.567

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  52 in total

Review 1.  Idiotypes and autoimmunity.

Authors:  D K Male
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

Review 2.  The structure of the T cell antigen receptor genes in normal and malignant T cells.

Authors:  M D Minden; T W Mak
Journal:  Blood       Date:  1986-08       Impact factor: 22.113

3.  Prolymphocytoid variants of chronic lymphocytic leukaemia: an immunological and morphological survey.

Authors:  C S Scott; H J Limbert; B E Roberts; A N Stark
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

4.  B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit.

Authors:  G A Pangalis; P A Roussou; C Kittas; S Kokkinou; P Fessas
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

5.  Cytogenetic and histologic correlations in malignant lymphoma.

Authors:  P R Koduru; D A Filippa; M E Richardson; S C Jhanwar; S R Chaganti; B Koziner; B D Clarkson; P H Lieberman; R S Chaganti
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

6.  The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.

Authors:  J M Bennett; K C Cain; J H Glick; G J Johnson; E Ezdinli; M J O'Connell
Journal:  J Clin Oncol       Date:  1986-10       Impact factor: 44.544

7.  Intermediate lymphocytic lymphoma: immunophenotypic and cytogenetic findings.

Authors:  D D Weisenburger; W G Sanger; J O Armitage; D T Purtilo
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

8.  The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features.

Authors:  J V Melo; D Catovsky; W M Gregory; D A Galton
Journal:  Br J Haematol       Date:  1987-01       Impact factor: 6.998

9.  The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements.

Authors:  J V Melo; J Wardle; M Chetty; J England; S M Lewis; D A Galton; D Catovsky
Journal:  Br J Haematol       Date:  1986-11       Impact factor: 6.998

10.  The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.

Authors:  J V Melo; D Catovsky; D A Galton
Journal:  Br J Haematol       Date:  1986-06       Impact factor: 6.998

View more
  54 in total

1.  Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia/prolymphocytic leukemia.

Authors:  A Miyata; K Kojima; T Yoshino; S Fujii; K Shinagawa; K Ichimura
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

2.  Splenic lymphoma with villous lymphocytes in two sisters.

Authors:  I Ribeiro; M M Costa; B A Fernandes; I Sousa; A Melo; A Parreira; L S Uva
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

3.  Leukaemic phase of mantle zone lymphoma.

Authors:  J Soler; F Ortuño; E Rubiol
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

4.  Chronic lymphoproliferative disorders at an Indian tertiary cancer centre - the panel sufficiency in the diagnosis of chronic lymphocytic leukaemia.

Authors:  Geeta V Patil Okaly; Ashwini R Nargund; Venkataswamy E; Prashanth K Jayanna; Chandra Rao Juvva; Shilpa Prabhudesai
Journal:  J Clin Diagn Res       Date:  2013-07-01

5.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

Review 6.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

7.  Karyotypic and molecular abnormalities in chronic lymphocytic leukaemia.

Authors:  C D Fegan; F E Davies
Journal:  Clin Mol Pathol       Date:  1996-08

8.  Expression of TIA-1 and TIA-2 in T cell malignancies and T cell lymphocytosis.

Authors:  E Matutes; E Coelho; M J Aguado; R Morilla; A Crawford; K Owusu-Ankomah; D Catovsky
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

9.  Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells.

Authors:  Xian Zhang; Takashi Machii; Itaru Matsumura; Sachiko Ezoe; Akira Kawasaki; Hirokazu Tanaka; Shuji Ueda; Hiroyuki Sugahara; Hirohiko Shibayama; Masao Mizuki; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

10.  Cytogenetic findings in 175 patients indicate that items of the Kiel classification should not be disregarded in the REAL classification of lymphoid neoplasms.

Authors:  H Nowotny; H Karlic; H Grüner; J Hirsch; M Vesely; A Nader; R Heinz
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.